BATTALION OIL CORP Income Taxes Disclosure
13. INCOME TAXES
Income tax benefit (provision) for the indicated periods is comprised of the following (in thousands):
Years Ended December 31, | ||||||
| 2025 | | 2024 | |||
Current: | ||||||
Federal | $ | — | $ | — | ||
State | — | — | ||||
— | — | |||||
Deferred: | ||||||
Federal | — | — | ||||
State | — | — | ||||
— | — | |||||
Total income tax benefit (provision) | $ | — | $ | — | ||
The actual income tax benefit (provision) differs from the expected income tax benefit (provision) as computed by applying the United States federal corporate income tax rate of 21% for the year ended December 31, 2025:
Amount | Percent | |||
$ | 2,495 | 21.00% | ||
State & Local Income Taxes, Net of Federal Income Tax Effect | ||||
State income taxes - Other, Net | — | 0.00% | ||
State Change in Valuation Allowance | — | 0.00% | ||
State income taxes - 2024 Return to Provision | — | 0.00% | ||
Changes in Valuation Allowances | (1,034) | (8.70)% | ||
Nontaxable or Nonductible Items | ||||
Percentage Depletion in Excess of Basis | — | 0.00% | ||
Federal RTP - Capital Loss Utilized | (1,473) | (12.40)% | ||
Other, net | 12 | 0.10% | ||
Effective Tax Rate | $ | — | 0.00% |
The following table presents the required disclosures prior to the adoption of ASU 2023-09 and reconciles the actual income tax benefit (provision) to the expected income tax benefit (provision) as computed by applying the U.S. federal corporate income tax rate of 21% for the period presented (in thousands):
Years Ended December 31, 2024 | ||||||
$ | 6,695 | |||||
Change in valuation allowance and related items | 107,573 | |||||
Permanent adjustments | (6) | |||||
Net operating loss write-off Section 382 | (785) | |||||
Non-deductible compensation | — | |||||
Capital loss carryover expiration | (113,940) | |||||
Merger transaction costs | 541 | |||||
Other | (78) | |||||
Total income tax benefit (provision) | $ | — | ||||
The components of net deferred income tax assets (liabilities) recognized are as follows (in thousands):
| December 31, 2025 | | December 31, 2024 | |||
Deferred noncurrent income tax assets: | ||||||
Net operating loss carry-forwards | $ | 203,791 | $ | 188,971 | ||
Built in loss adjustment Section 382 | 693 | 693 | ||||
Capital loss carryforward | — | — | ||||
Stock-based compensation expense | 1,733 | 1,723 | ||||
Asset retirement obligations | 4,376 | 4,023 | ||||
Book-tax differences in property basis | 80,228 | 93,974 | ||||
Unrealized hedging transactions | — | 1,735 | ||||
Disallowed interest Section 163(j) | 28,811 | 25,011 | ||||
Embedded derivative liability | — | — | ||||
Operating lease liability | 182 | 103 | ||||
Amortization of debt issuance costs | 1,226 | — | ||||
Loss on extinguishment of debt | 1,573 | 1,573 | ||||
Other | 450 | 703 | ||||
Gross deferred noncurrent income tax assets | 323,063 | 318,509 | ||||
Valuation allowance | (316,411) | (317,445) | ||||
Deferred noncurrent income tax assets | $ | 6,652 | $ | 1,064 | ||
Deferred noncurrent income tax liabilities: | ||||||
Basis difference in debt | $ | (615) | $ | (615) | ||
Investment in unconsolidated subsidiary | (270) | (270) | ||||
Amortization of debt issuance costs | — | (84) | ||||
Embedded derivative liability | (1,145) | — | ||||
Unrealized hedging transactions | (4,446) | — | ||||
Lease right of use | (176) | (95) | ||||
Deferred noncurrent income tax liabilities | $ | (6,652) | $ | (1,064) | ||
Net noncurrent deferred income tax assets (liabilities) | $ | — | $ | — | ||
The amount of U.S. consolidated Net Operating Losses (“NOLs”) available as of December 31, 2025 after attribute reduction is estimated to be approximately $1.4 billion, but the amount after attribute reduction and the Section 382 limitation is $970.4 million. Of this amount, $88.9 million is subject to the 20-year carryforward period and will expire in 2037. The remaining $881.5 million may be carried forward indefinitely but is in part subject to a Section 382 limitation.
The Company assesses the recoverability of its deferred tax assets each period by considering whether it is more likely than not that all or a portion of the deferred tax assets will not be realized. The Company considers all available evidence (both positive and negative) in determining whether a valuation allowance is required. The Company evaluated possible sources of taxable income that may be available to realize the benefit of deferred tax assets, including projected future taxable income, the reversal of existing temporary differences, taxable income in carryback years and available tax planning strategies in making this assessment. As a result of the Company’s analysis, it was concluded that as of December 31, 2025, a valuation allowance should continue to be applied against the Company’s net deferred tax asset. The Company recorded a valuation allowance as of December 31, 2025 of $316.4 million, a decrease of $1.0 million from December 31, 2024. The Company will continue to monitor facts and circumstances in the reassessment of the likelihood that operating loss carryforwards, credits and other deferred tax assets will be utilized.
ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of income tax positions taken or expected to be taken in an income tax return. For those benefits to be recognized, an income tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company has no unrecognized tax benefits for the year ended December 31, 2025 and 2024. Accordingly, there is no amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate and there is no amount of interest or penalties currently recognized in the consolidated statements of operations in “Interest expense and other” or consolidated balance sheets as of December 31, 2025 and 2024. In addition, the Company does not believe that there are any positions for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or decrease within the next twelve months.
Tax audits may be ongoing at any point in time. Tax liabilities are recorded based on estimates of additional taxes which may be due upon the conclusion of these audits. Estimates of these tax liabilities are made based upon prior experience and are updated for changes in facts and circumstances. However, due to the uncertain and complex application of tax regulations, it is possible that the ultimate resolution of audits may result in liabilities which could be materially different from these estimates.
Generally, the Company’s income tax years 2021 through 2025 remain open for federal purposes and are subject to examination by Federal tax authorities. The Company's income tax returns are also subject to audit by the tax authorities in Louisiana, Mississippi, North Dakota, Oklahoma, Texas, Pennsylvania, Ohio and certain other state taxing jurisdictions where the Company has, or previously had, operations. In certain jurisdictions the Company operates through more than one legal entity, each of which may have different open years subject to examination. The open years for state purposes can vary from the normal three-year statue expiration period for federal purposes.
On July 4, 2025, the One Big Beautiful Bill Act (the “OBBBA”) was enacted in the U.S. The OBBBA includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Cust and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. The legislation has multiple effective dates, with certain provisions effective in 2025 and other implemented through 2027. These provisions had no impact on the Company’s consolidated financial statements for the year ended December 31, 2025. The Company is evaluating the impact of provisions required at future dates but does not expect such to have a material impact on its results of operations, cash flows or financial condition.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 23, 2026 | Showing above |
| 2024 | Mar 31, 2025 | |
| 2023 | Apr 1, 2024 | |
| 2022 | Mar 30, 2023 | |
| 2021 | Mar 7, 2022 | |
| 2020 | Mar 8, 2021 | |
| 2019 | Mar 25, 2020 | |
| 2018 | Mar 12, 2019 | |
| 2017 | Mar 1, 2018 | |
| 2016 | Mar 1, 2017 | |
| 2015 | Feb 26, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.